CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 176 enrolled
Drug / intervention
Orthica Soft Multi Mini and Orthica Fish EPA Minidietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02498106
NCT02498106N/ACompleted
CompareCT.gov

Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Supplementation of Multivitamins, Minerals and n-3 Fatty Acids

Leiden University Medical Center·interventional·Posted Jul 15, 2015·Updated Nov 1, 2019

In Brief

A clinical study evaluating Orthica Soft Multi Mini and Orthica Fish EPA Mini for Psychiatric Hospitalization. Completed, enrolled 176 participants across 6 sites.

Detailed Summary

The overall goal of this study is to investigate whether the daily administration of multivitamins, minerals and n-3 fatty acids will reduce aggression in long-term psychiatric inpatients and will thereby reduce costs of care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsychiatric Hospitalization
CountriesNetherlands
CollaboratorsAtrium Innovations

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 15, 2015
Enrollment StartMay 1, 2015
Primary CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 11.0 years ago

Interventions

Orthica Soft Multi Mini and Orthica Fish EPA Minidietary

daily intake of 2 Orthica Soft Multi Mini capsules (containing vitamins \[B1, B2, B3, B5, B6, B11, B12, C, D, E, Beta Carotene\] and minerals \[Iodine, Copper, Selenium, Iron, Zinc, Chrome, Manganese\]) and 1 Orthica Fish EPA Mini capsule (containing n-3FA: eicosapentaenic acid \[EPA\] and docosahexaenic acid \[DHA\])